Literature DB >> 34050331

Fundamental mechanistic insights from rare but paradigmatic neuroimmunological diseases.

Heinz Wiendl1, Catharina C Gross2, Jan Bauer3, Doron Merkler4, Alexandre Prat5, Roland Liblau6,7.   

Abstract

The pathophysiology of complex neuroimmunological diseases, such as multiple sclerosis and autoimmune encephalitis, remains puzzling - various mechanisms that are difficult to dissect seem to contribute, hampering the understanding of the processes involved. Some rare neuroimmunological diseases are easier to study because their presentation and pathogenesis are more homogeneous. The investigation of these diseases can provide fundamental insights into neuroimmunological pathomechanisms that can in turn be applied to more complex diseases. In this Review, we summarize key mechanistic insights into three such rare but paradigmatic neuroimmunological diseases - Susac syndrome, Rasmussen encephalitis and narcolepsy type 1 - and consider the implications of these insights for the study of other neuroimmunological diseases. In these diseases, the combination of findings in humans, different modalities of investigation and animal models has enabled the triangulation of evidence to validate and consolidate the pathomechanistic features and to develop diagnostic and therapeutic strategies; this approach has provided insights that are directly relevant to other neuroimmunological diseases and applicable in other contexts. We also outline how next-generation technologies and refined animal models can further improve our understanding of pathomechanisms, including cell-specific and antigen-specific CNS immune responses, thereby paving the way for the development of targeted therapeutic approaches.

Entities:  

Mesh:

Year:  2021        PMID: 34050331     DOI: 10.1038/s41582-021-00496-7

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


  116 in total

Review 1.  The changing concepts in the neuropathology of acquired demyelinating central nervous system disorders.

Authors:  Hans Lassmann
Journal:  Curr Opin Neurol       Date:  2019-06       Impact factor: 5.710

Review 2.  Antibody-Mediated Encephalitis.

Authors:  Josep Dalmau; Francesc Graus
Journal:  N Engl J Med       Date:  2018-03-01       Impact factor: 91.245

Review 3.  T cell responses in the central nervous system.

Authors:  Thomas Korn; Axel Kallies
Journal:  Nat Rev Immunol       Date:  2017-01-31       Impact factor: 53.106

Review 4.  The search for the target antigens of multiple sclerosis, part 1: autoreactive CD4+ T lymphocytes as pathogenic effectors and therapeutic targets.

Authors:  Reinhard Hohlfeld; Klaus Dornmair; Edgar Meinl; Hartmut Wekerle
Journal:  Lancet Neurol       Date:  2015-12-24       Impact factor: 44.182

Review 5.  The search for the target antigens of multiple sclerosis, part 2: CD8+ T cells, B cells, and antibodies in the focus of reverse-translational research.

Authors:  Reinhard Hohlfeld; Klaus Dornmair; Edgar Meinl; Hartmut Wekerle
Journal:  Lancet Neurol       Date:  2015-12-24       Impact factor: 44.182

6.  Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.

Authors:  Josep Dalmau; Amy J Gleichman; Ethan G Hughes; Jeffrey E Rossi; Xiaoyu Peng; Meizan Lai; Scott K Dessain; Myrna R Rosenfeld; Rita Balice-Gordon; David R Lynch
Journal:  Lancet Neurol       Date:  2008-10-11       Impact factor: 44.182

Review 7.  Multiple sclerosis, and other demyelinating and autoimmune inflammatory diseases of the central nervous system.

Authors:  Clara Matute-Blanch; Xavier Montalban; Manuel Comabella
Journal:  Handb Clin Neurol       Date:  2017

8.  GDP-l-fucose synthase is a CD4+ T cell-specific autoantigen in DRB3*02:02 patients with multiple sclerosis.

Authors:  Raquel Planas; Radleigh Santos; Paula Tomas-Ojer; Carolina Cruciani; Andreas Lutterotti; Wolfgang Faigle; Nicole Schaeren-Wiemers; Carmen Espejo; Herena Eixarch; Clemencia Pinilla; Roland Martin; Mireia Sospedra
Journal:  Sci Transl Med       Date:  2018-10-10       Impact factor: 17.956

Review 9.  Neuromyelitis optica: clinical features, immunopathogenesis and treatment.

Authors:  S Jarius; B Wildemann; F Paul
Journal:  Clin Exp Immunol       Date:  2014-05       Impact factor: 4.330

10.  Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells in Multiple Sclerosis.

Authors:  Ivan Jelcic; Faiez Al Nimer; Jian Wang; Verena Lentsch; Raquel Planas; Ilijas Jelcic; Aleksandar Madjovski; Sabrina Ruhrmann; Wolfgang Faigle; Katrin Frauenknecht; Clemencia Pinilla; Radleigh Santos; Christian Hammer; Yaneth Ortiz; Lennart Opitz; Hans Grönlund; Gerhard Rogler; Onur Boyman; Richard Reynolds; Andreas Lutterotti; Mohsen Khademi; Tomas Olsson; Fredrik Piehl; Mireia Sospedra; Roland Martin
Journal:  Cell       Date:  2018-08-30       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.